Systematic Financial Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-50,800
Closed -$1.22M 686
2017
Q1
$1.22M Buy
50,800
+35
+0.1% +$858 0.02% 582
2016
Q4
$1.29M Buy
50,765
+8,890
+21% +$234K 0.02% 566
2016
Q3
$1.26M Sell
41,875
-12,500
-23% -$343K 0.02% 533
2016
Q2
$1.28M Sell
54,375
-1,310
-2% -$28.7K 0.02% 520
2016
Q1
$1.02M Buy
55,685
+175
+0.3% +$3.29K 0.01% 526
2015
Q4
$1.13M Sell
55,510
-14,910
-21% -$317K 0.01% 548
2015
Q3
$1.54M Sell
70,420
-36,390
-34% -$854K 0.02% 565
2015
Q2
$2.5M Buy
+106,810
New +$2.68M 0.02% 444

Other funds holding SRDX

Systematic Financial Management's SRDX Position: Q2 2017 in Review

Systematic Financial Management sold out of Surmodics (SRDX) in Q2 2017, closing a stake of 50,800 shares — an estimated $1.22M sold.

Systematic Financial Management first reported a position in SRDX in Q2 2015 and held it in 8 quarters. The position peaked at $2.5M in Q2 2015. 114 funds tracked by Wall St. Rank hold SRDX as of Q2 2017.

  • Systematic Financial Management reported no remaining Surmodics position as of Q2 2017 after selling out during the quarter.
  • Systematic Financial Management sold 50,800 Surmodics shares in Q2 2017, an estimated $1.22M.
  • Systematic Financial Management first reported a position in Surmodics in Q2 2015 and held it in 8 quarters.
  • Systematic Financial Management's Surmodics position peaked at $2.5M in Q2 2015.
  • 114 funds tracked by Wall St. Rank held Surmodics as of Q2 2017.

Based on Systematic Financial Management's 13F filing for Q2 2017, filed 10 Aug 2017.